1887

Abstract

Several features make bovine herpesvirus 4 (BoHV-4) attractive as a backbone for use as a viral expression vector and/or as a model to study gammaherpesvirus biology. However, these developments have been impeded by the difficulty in manipulating its large genome using classical homologous recombination in eukaryotic cells. In the present study, the feasibility of exploiting bacterial artificial chromosome (BAC) cloning and prokaryotic recombination technology for production of BoHV-4 recombinants was explored. Firstly, the BoHV-4 genome was BAC cloned using two potential insertion sites. Both sites of insertion gave rise to BoHV-4 BAC clones stably maintained in bacteria and able to regenerate virions when transfected into permissive cells. Reconstituted virus replicated comparably to wild-type parental virus and the -flanked BAC cassette was excised by growing them on permissive cells stably expressing Cre recombinase. Secondly, BoHV-4 recombinants expressing anti-complement protein I or II (IRAC I/II) were produced using a two-step mutagenesis procedure in . Both recombinants induced expression of high levels of functional IRAC molecules in the supernatant of infected cells. This study demonstrates that BAC cloning and prokaryotic recombination technology are powerful tools for the development of BoHV-4 as an expression vector and for further fundamental studies of this gammaherpesvirus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80718-0
2005-04-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/4/vir860907.html?itemId=/content/journal/jgv/10.1099/vir.0.80718-0&mimeType=html&fmt=ahah

References

  1. Adler H., Messerle M., Wagner M., Koszinowski U. H. 2000; Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J Virol 74:6964–6974 [CrossRef]
    [Google Scholar]
  2. Borst E. M., Hahn G., Koszinowski U. H., Messerle M. 1999; Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli : a new approach for construction of HCMV mutants. J Virol 73:8320–8329
    [Google Scholar]
  3. Brune W., Menard C., Hobom U., Odenbreit S., Messerle M., Koszinowski U. H. 1999; Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis. Nat Biotechnol 17:360–364 [CrossRef]
    [Google Scholar]
  4. Cicin-Sain L., Brune W., Bubic I., Jonjic S., Koszinowski U. H. 2003; Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo. J Virol 77:8249–8255 [CrossRef]
    [Google Scholar]
  5. Coligan J. E., Kruisbeek A. M., Margulies D. H., Shevach E. M. Strober W. (editors) 1992 Current Protocols in Immunology New York: Greene Publishing Associates and Wiley Interscience;
    [Google Scholar]
  6. Daix V., Godfroid E., Pastoret P. P., Bollen A., Vanderplasschen A. 2001; New anti-complement proteins. Patent no. PCT 01870143.3:
    [Google Scholar]
  7. Dubuisson J., Pastoret P. P., Thiry E. 1991; Temporal control of bovine herpesvirus type 4 glycoprotein synthesis. J Gen Virol 72:1429–1434 [CrossRef]
    [Google Scholar]
  8. Fowler P., Efstathiou S. 2004; Vaccine potential of a murine gammaherpesvirus-68 mutant deficient for ORF73. J Gen Virol 85:609–613 [CrossRef]
    [Google Scholar]
  9. Giles M. S., Smith P. G., Coletta P. L., Hall K. T., Whitehouse A. 2003; The herpesvirus saimiri ORF 73 regulatory region provides long-term transgene expression in human carcinoma cell lines. Cancer Gene Ther 10:49–56 [CrossRef]
    [Google Scholar]
  10. Gillet L., Minner F., Detry B. & 7 other authors; 2004; Investigation of the susceptibility of human cell lines to bovine herpesvirus 4 infection: demonstration that human cells can support a nonpermissive persistent infection which protects them against tumor necrosis factor alpha-induced apoptosis. J Virol 78:2336–2347 [CrossRef]
    [Google Scholar]
  11. Hobom U., Brune W., Messerle M., Hahn G., Koszinowski U. H. 2000; Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J Virol 74:7720–7729 [CrossRef]
    [Google Scholar]
  12. Kootstra N. A., Verma I. M. 2003; Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol 43:413–439 [CrossRef]
    [Google Scholar]
  13. Mahony T. J., McCarthy F. M., Gravel J. L., West L., Young P. L. 2002; Construction and manipulation of an infectious clone of the bovine herpesvirus 1 genome maintained as a bacterial artificial chromosome. J Virol 76:6660–6668 [CrossRef]
    [Google Scholar]
  14. Markine-Goriaynoff N., Georgin J. P., Goltz M., Zimmermann W., Broll H., Wamwayi H. M., Pastoret P. P., Sharp P. M., Vanderplasschen A. 2003; The core 2 β -1,6- N -acetylglucosaminyltransferase-mucin encoded by bovine herpesvirus 4 was acquired from an ancestor of the African buffalo. J Virol 77:1784–1792 [CrossRef]
    [Google Scholar]
  15. Markine-Goriaynoff N., Gillet L., Karlsen O. A., Haarr L., Minner F., Pastoret P. P., Fukuda M., Vanderplasschen A. 2004; The core 2 β -1,6- N -acetylglucosaminyltransferase-M encoded by bovine herpesvirus 4 is not essential for virus replication despite contributing to post-translational modifications of structural proteins. J Gen Virol 85:355–367 [CrossRef]
    [Google Scholar]
  16. Meseda C. A., Schmeisser F., Pedersen R., Woerner A., Weir J. P. 2004; DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome. Virology 318:420–428 [CrossRef]
    [Google Scholar]
  17. Messerle M., Crnkovic I., Hammerschmidt W., Ziegler H., Koszinowski U. H. 1997; Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A 94:14759–14763 [CrossRef]
    [Google Scholar]
  18. Naeem K., Caywood D. D., Werdin R. E., Goyal S. M. 1990; Evaluation of pregnant rabbits as a laboratory model for bovid herpesvirus-4 infection. Am J Vet Res 51:640–644
    [Google Scholar]
  19. Petherbridge L., Howes K., Baigent S. J., Sacco M. A., Evans S., Osterrieder N., Nair V. 2003; Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. J Virol 77:8712–8718 [CrossRef]
    [Google Scholar]
  20. Pfeifer A., Verma I. M. 2001; Gene therapy: promises and problems. Annu Rev Genomics Hum Genet 2:177–211 [CrossRef]
    [Google Scholar]
  21. Rossiter P. B., Gumm I. D., Stagg D. A., Conrad P. A., Mukolwe S., Davies F. G., White H. 1989; Isolation of bovine herpesvirus-3 from African buffaloes ( Syncerus caffer . Res Vet Sci 46:337–343
    [Google Scholar]
  22. Smith G. A., Enquist L. W. 2000; A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis. Proc Natl Acad Sci U S A 97:4873–4878 [CrossRef]
    [Google Scholar]
  23. Stavropoulos T. A., Strathdee C. A. 1998; An enhanced packaging system for helper-dependent herpes simplex virus vectors. J Virol 72:7137–7143
    [Google Scholar]
  24. Suter M., Lew A. M., Grob P., Adema G. J., Ackermann M., Shortman K., Fraefel C. 1999; BAC-VAC, a novel generation of (DNA) vaccines: a bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1. Proc Natl Acad Sci U S A 96:12697–12702 [CrossRef]
    [Google Scholar]
  25. Thiry E., Pastoret P. P., Calberg-Bacq C. M. 1981; Isolement d'un herpesvirus chez un taureau infertile. Ann Méd Vét 125:143
    [Google Scholar]
  26. Thiry E., Bublot M., Dubuisson J., Van Bressem M. F., Lequarre A. S., Lomonte P., Vanderplasschen A., Pastoret P. P. 1992; Molecular biology of bovine herpesvirus type 4. Vet Microbiol 33:79–92 [CrossRef]
    [Google Scholar]
  27. Tischer B. K., Schumacher D., Beer M. & 7 other authors; 2002; A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens. J Gen Virol 83:2367–2376
    [Google Scholar]
  28. Vanderplasschen A., Smith G. L. 1997; A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors. J Virol 71:4032–4041
    [Google Scholar]
  29. Vanderplasschen A., Bublot M., Dubuisson J., Pastoret P. P., Thiry E. 1993; Attachment of the gammaherpesvirus bovine herpesvirus 4 is mediated by the interaction of gp8 glycoprotein with heparinlike moieties on the cell surface. Virology 196:232–240 [CrossRef]
    [Google Scholar]
  30. Vanderplasschen A., Markine-Goriaynoff N., Lomonte P. & 8 other authors; 2000; A multipotential β -1,6- N -acetylglucosaminyl-transferase is encoded by bovine herpesvirus type 4. Proc Natl Acad Sci U S A 97:5756–5761 [CrossRef]
    [Google Scholar]
  31. Verma I. M., Somia N. 1997; Gene therapy – promises, problems and prospects. Nature 389:239–242 [CrossRef]
    [Google Scholar]
  32. Wagner M., Ruzsics Z., Koszinowski U. H. 2002; Herpesvirus genetics has come of age. Trends Microbiol 10:318–324 [CrossRef]
    [Google Scholar]
  33. Zimmermann W., Broll H., Ehlers B., Buhk H. J., Rosenthal A., Goltz M. 2001; Genome sequence of bovine herpesvirus 4, a bovine rhadinovirus, and identification of an origin of DNA replication. J Virol 75:1186–1194 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80718-0
Loading
/content/journal/jgv/10.1099/vir.0.80718-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error